BASEL LIFE 2018

11–14 September 2018

Congress Center Basel
Switzerland

Programme Overview

Tuesday 11 September 2018

16.45 – 18.00

EMBO Session

Welcome and Opening session

Chair:
Maria Leptin (EMBO, Heidelberg, Germany)

16.45
Welcome
Josef Helfenstein (Kunstmuseum Basel, Basel, Switzerland)
Susan Gasser (Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland)
Gerd Folkers (ETH, Zürich, Switzerland)

17.00
Art and Science
Michael N. Hall (University of Basel, Switzerland)
Jacques Herzog (Herzog & de Meuron, Basel, Switzerland)

Basel Kunstmuseum

18.00 – 19.30

EMBO Session

Welcome reception
Attendees are invited to visit the art galleries of the museum (18:30 – 19:30, free admission)

Discover the art galleries of the Kunstmuseum: Ask Me Guides will be happy to answer your questions.

Basel Kunstmuseum

Wednesday 12 September 2018

09.00 – 09.45

EMBO Scientific Session

Keynote lecture 1

Chair:
René Bernards (Netherlands Cancer Institute, Amsterdam, Netherlands)

09.00
Novel therapeutic approaches
Jeffrey Engelman (Novartis, Boston, United States)

Montreal

09.45 – 10.15

Coffee break at the exhibition

10.15 – 12.00

EMBO Scientific Session

Plenary session 1: Cancer I

Chair:
René Bernards (Netherlands Cancer Institute, Amsterdam, Netherlands)

10.15
Tumour-stroma interactions in breast cancer metastasis
Clare Isacke (The Institute of Cancer Research, London, United Kingdom)

10.40
Translation control in melanoma
Caroline Robert (Institut Gustave Roussy, Paris, France)

11.05
Cancer evolution as a therapeutic target

Alberto Bardelli (University of Torino, Candiolo, Italy)

11.30
Cell plasticity and lineage commitment in liver tumorigenesis
Lars Zender (Tübingen University, Germany)

Montreal

12.00 – 13.45

Lunch break

13.45 – 15.30

EMBO Scientific Session

Parallel session 1: Plant disease and pathogens

Chair:
Regine Kahmann (Max Planck Institute for Terrestrial Microbiology, Marburg, Germany)

13.45                            
Effectors to go: unexpected insights from a plant pathogenic fungus
Regine Kahmann (Max Planck Institute for Terrestrial Microbiology, Marburg, Germany)

14.10                            
Dynamics of host adaptation in fungal pathogens
Antonio Di Pietro (University of Cordoba, Cordoba, Spain)

14.35                            
Secretion and delivery of effector proteins from a plant pathogen to its host
Paul Birch (The James Hutton Institute, Dundee, United Kingdom)

15.00                            
Determination of the host range of the fungal plant pathogen Verticillium
Bart Thomma (University of Wageningen, Netherlands)

Montreal

13.45 – 15.30

EMBO Scientific Session

Parallel session 2: Cancer II

Chair:
Charles Swanton (The Francis Crick Institute, London, United Kingdom)

13.45
Cancer evolution, adaptation and immune evasion
Charles Swanton (The Francis Crick Institute, London, United Kingdom)

14.10                            
Understanding the role of metabolism in cancer

Matthew G. Vander Heiden (Koch Institute for Integrative Cancer Research, Cambridge, United States)

14.35
Circulating tumour cells: a multi-use biomarker
Caroline Dive (The University of Manchester, United Kingdom)

Abstract presentations

15.00
The protein histidine phosphatase LHPP is a tumor suppressor
S.K. Hindupur1, M. Colombi1, S.R. Fuhs2, M.S. Matter3, Y. Guri1, K. Adam2, M. Cornu1, S. Piscuoglio3, C.Y. Ng3, C. Betz1, D. Liko1, L. Quagliata3, S. Moes1, P. Jenoe1, L.M. Terracciano3, M.H. Heim4, T. Hunter2, M.N. Hall1
1University of Basel / Biozentrum, Basel, Switzerland, 2Salk Institute for Biological Studies, California, CA, United States, 3Universitätsspital Basel / Institute of Pathology, 4Universitätsspital Basel / Department of Biomedicine, Basel, Switzerland

15.15                            
Modelling mutant IDH2 leukemia evolution identifies vulnerabilities and effective combination therapy
V. Mugoni1,2, R. Panella1, G. Cheloni1, M. Chen1, O. Pozdnyakova3, D. Stroopinsky1, J. Guarnerio1, E. Monteleone1,4, J.D. Lee1, L. Mendez1, A. Venugopal Menon1, J.C. Aster3, A. Lane5, R.M. Stone5, I. Galinsky5, J.C. Zamora6, F. Lo-Coco7,8, M.K. Bhasin9, D. Avigan1, L. Longo1, J. Clohessy1,2,10, P.P. Pandolfi2
1Cancer Research Institute, Beth Israel Deaconess Cancer Center, Department of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., 2Ludwig Center at Harvard, Harvard Medical School, 3Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States, 4Molecular Biotechnology Center and Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy, 5Department of Medical Oncology, Dana-Farber Cancer Institute; Harvard Medical School, Boston, MA, United States, 6Biobanco La Fe - Instituto de Investigation Sanitaria La Fe (IIS-LA FE), Valencia, Spain, 7Department of Biomedicine and Prevention, University of Rome 'Tor Vergata', 8Neuro-Oncohematology Unit, Santa Lucia Foundation, Rome, Italy, 9Division of IMBIO, Department of Medicine, BIDMC Genomics, Proteomics, Bioinformatics and Systems Biology Center, Harvard Medical School and Beth Israel Deaconess Medical Center, 10Preclinical Murine Pharmacogenetics Core, Beth Israel Deaconess Cancer Center, Dana Farber/Harvard Cancer Center, Boston, MA, United States

Singapore

15.30 – 16.30

EMBO Flash Talks & Posters

EMBO Flash talks (session 1)

Cancer

15.30     P110          
Mechanisms of oncogene-induced DNA replication stress
M. Macheret, T.D. Halazonetis
Molecular Biology, University of Geneva, Geneva, Switzerland

15.34     P111          
DNA-PK regulates the radiosensitivity and oncogenicity of MET-addicted cancer cell lines via a novel MET phosphosite
J. Koch1, S.M. Roth1, A. Quintin1, J. Gavini2, E. Orlando1, M. Medo1, R. Aebersold3,4, D.M. Stroka2, D.M. Aebersold1, Y. Zimmer1, M. Medová1
1Department for BioMedical Research, Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, 2Department for BioMedical Research, Visceral Surgery, Inselspital, Bern University Hospital and University of Bern, Bern, 3Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, 4Faculty of Science, University of Zürich, Zürich, Switzerland

15.38     P112          
The mammalian Target of Rapamycin Complex 2 (mTORC2) promotes tumorigenesis via lipid synthesis
Y. Guri1, M. Colombi1, E. Dazert1, S. Kumar1, S. Moes2, P. Jenoe2, J. Roszik3, M. Heim4, H. Riezman5, I. Riezman5, M.N. Hall1, Biozentrum, University of Basel, Basel, Switzerland
1Biozentrum | Growth and Development, University of Basel, 2University of Basel / Biozentrum, Basel, Switzerland, 3Melanoma Medical Oncology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States, 4Hepatology, Universitätsspital Basel, Basel, 5University of Geneva, Geneva, Switzerland

15.42     P113          
Molecular mechanisms mediating responsiveness to targeted cancer therapy
E. Dazert1, M. Colombi1, T. Boldanova2, C. Etter1, C.K.Y. Ng3, T. Habluetzel1, S. Wieland2, S. Ketterer2, T. Bock1, S. Moes1, P. Jenoe1, A. Schmidt1, L. Terracciano3, M. Heim2, M.N. Hall1
1Biozentrum / University of Basel, 2Department of Biomedicine / University Hospital Basel, 3Molecular Pathology / University Hospital Basel, Basel, Switzerland

15.46     P114          
A highly miniaturized system for anti-cancer compound screening on primary cells and cancer spheroids
A. Popova1, S. Dietrich2, P. Levkin1
1Institute for Toxicology and Genetics, Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, 2Hematology and Oncology, University Hospital Heidelberg, Heidelberg, Germany

15.50     P115          
Role of CDK8 in hepatocellular carcinoma
K. Bacevic, S. Prieto, J. Ursic-Bedoya, C. Dohet, A. Camasses, D. Fisher, U. Hibner, D. Gregoire
Institute of Molecular Genetics, Montpellier, France

15.54     P116          
Potassium channels and membrane polarization control membrane translocation of cell-penetrating peptides
E. Trofimenko1, M. Heulot1, N. Chevalier1, S. Michel1, M. Serulla Llorens1, G. Vantomme2, Y. Arribat1, G. Dubuis1, J. Puyal2, F. Amati1, A. Luthi2, C. Widmann1
1Department of Physiology, 2Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland

Metabolic disorders – diabetes/obesity

15.58     P117          
Insulin resistance causes inflammation in adipose tissue
M. Shimobayashi1, V. Albert1, B. Woelnerhanssen2, I.C. Frei1, D. Weissenberger1, A.C. Meyer-Gerspach2, N. Clement2, S. Moes1, M. Colombi1, J.A. Meier1, M.M. Swierczynska1, P. Jenö1, C. Beglinger2, R. Peterli1, M.N. Hall1
1University of Basel / Biozentrum, 2St. Claraspital, Basel, Switzerland

16.02     P118          
Lipid metabolism and intestinal organoid development
A. Xavier da Silveira dos Santos1, F. Maurer1, S. Iftkhar1,2, K. Volkmann1, C. Genoud1, P. Liberali1
1Quantitative Biology, Friedrich Miescher Institute for Biomedical Research, 2Biozentrum / University of Basel, Basel, Switzerland

Inflammation

16.06     P119          
T cell costimulation blockade blunts pressure overload-induced heart failure
E. Martini1, M. Kallikourdis1,2, P. Carullo3,4, C. Sardi1, C.M. Greco3, G. Roselli1, F. Riva5, A.M. Ormbostad Berre6, T.O. Stølen6, A. Fumero7, G. Faggian8, E. Di Pasquale3,4, L. Elia3, C. Rumio9, D. Catalucci4,10, R. Papait3, G. Condorelli2,3
1Adaptive Immunity Laboratory, Humanitas Research Hospital, 2Department of Biomedical Sciences, Humanitas University, 3Department of Cardiovascular Medicine, Humanitas Research Hospital, 4Institute of Genetic and Biomedical Research (IRGB), National Research Council of Italy, Rozzano, 5Department of Veterinary Sciences and Public Health (DIVET), University of Milan, Milano, Italy, 6Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway, 7Cardiac Surgery, Humanitas Research Hospital, Rozzano, 8Department of Cardiac Surgery, University of Verona, Verona, 9Dipartimento di Scienze Farmacologiche e Biomolecolar, University of Milan, Milano, 10Laboratory of Signal Transduction in Cardiac Pathologies, Humanitas Research Hospital, Rozzano, Italy

Neurodegenerative disease

16.10     P120          
In vitro Labeling of Human Wharton's Jelly-derived Mesenchymal Stem Cells with Dextran-coated Superparamagnetic Iron Oxide Nanoparticles by a New Bio-Mimicry Method
M. Mehdizadeh1, R. Shabani2, F. Ghiami2
1Cellular and Molecular Research Center, Faculty of Advanced Technologies in Medicine, Department of Anatomical Sciences, 2Department of Anatomical Sciences, School of Medicine, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran

16.14     P121          
Comparative in silico analysis of bacterial and human neutral sphingomyelinases

B. Yagci, E. Ozkirimli Olmez, K. Ulgen
Chemical Engineering, Bogazici University, Istanbul, Turkey

MipTec stage

15.30 – 16.30

EMBO Poster Session

EMBO Poster session 1

Poster exhibition

16.30 – 17.30

EMBO Scientific Session

Louis-Jeantet Prize lectures

Chair:
Paul Nurse (The Francis Crick Institute, London, United Kingdom)

16.30
Deconstructing and reconstructing the vasculature
Christer Betsholtz (Uppsala University, Sweden)

17.00
Dissecting human antibody responses: useful, basic and surprising findings

Antonio Lanzavecchia (Institute for Research in Biomedicine, Bellinzona, Switzerland)

Montreal

Thursday 13 September 2018

09.00 – 09.45

EMBO Scientific Session

Keynote lecture 2

Chair:
Karen Avraham (Tel Aviv University, Israel)

09.00
Space and memory in the brain

May-Britt Moser (NTNU, Trondheim, Norway)

Montreal

09.45 – 10.15

Coffee break at the exhibition

10.15 – 12.00

EMBO Scientific Sessions

Plenary session 2: Microbial disease and pathogens

Chair:
Philippe Sansonetti (Insitut Pasteur, Paris, France)

10.15
Gut microbiome and intestinal epithelial regeneration: decrypting signals in the crypt
Philippe Sansonetti (Insitut Pasteur, Paris, France)

10.40
Pathoecology and evolution of the cholera-causing pathogen Vibrio cholerae
Melanie Blokesch (EPFL, Lausanne, Switzerland)

11.05
Programmable RNA antibiotics for microbiome editing

Jörg Vogel (Helmholtz Centre for Infection Research, Germany)

11.30
How Salmonella deals with host immune responses
David Holden (Imperial College London, United Kingdom)

Montreal

12.00 – 13.45

Lunch break

13.45 – 15.30

EMBO Scientific Session

Parallel session 3: Microbiota

Chair:
François Leulier (IGFL, Lyon, France)

13.45
The microbiome and animal linear growth promotion
François Leulier (IGFL, Lyon, France)

14.10
Personalizing treatments using microbiome and clinical data

Eran Segal (Weizmann Institute of Science, Rehovot, Israel)

14.35
tba
Ami Bhatt (Stanford University, Palo Alto, United States)

15.00
Innovation in nutrition and health based on microbiome research
Nathalie Delzenne (UCLouvain/Louvain Drug Research Institute, Brussels, Belgium)

Montreal

13.45 – 15.30

EMBO Scientific Session

Parallel session 4: Sensory function and deficit

Chair:
Karen Avraham (Tel Aviv University, Israel)

13.45                            
Epigenomics of the auditory system: Implications for deafness
Karen Avraham (Tel Aviv University, Israel)

14.10
Gut feelings: delineating sensory signaling pathways in the intestine
David Julius (University of California, San Francisco, United States)

14.35
Optogenetics for vision restoration - translation from mice to primates
Deniz Dalkara (Institut de la Vision, Paris, France) 

15.00
Cell type specification during development of proprioception - the body's 'Sixth Sense'
Yoram Groner (The Weizmann Institute of Science, Rehovot, Israel)

Singapore

15.30 – 16.00

Coffee break at the exhibition

16.00 – 17.15

EMBO Scientific Session

Plenary session 3: Inflammation

Chair:
Yinon Ben-Neriah (The Hebrew University Hadassah Medical School, Jerusalem, Israel)

16.00
CKI alpha inhibition-mediated p53 activation and parainflammation – implications for cancer therapy
Yinon Ben-Neriah (The Hebrew University Hadassah Medical School, Jerusalem, Israel)

16.25
Inflammation: linking homeostasis and defense
Ruslan Medzhitov (Yale University, New Haven, United States)

16.50
Immune suppression: how to convert conventional T cells into regulatory T cells
Shimon Sakaguchi (Osaka University, Japan)

Montreal

17.30 – 18.30

EMBO Flash Talks & Posters

EMBO Flash talks (session 2)

Microbiota

17.30     P122          
Cancer Cell-Microbiota Interactions in the Human Skin Microbiome of Cutaneous T Cell Lymphoma
C. Dehner, W. Ruff, F. Foss, M. Girardi, M. Kriegel
Yale School of Medicine, New Haven, CT, United States

17.34     P123          
Experimental evolution of a fungal pathogen into a gut symbiont
G.H.W. Tso1, J.A. Reales-Calderon1, A.S.M. Tan1, X.H. Sem1, G.T.T. Le1, T.G. Tan1, G.C. Lai1, K.G. Srinivasan1, M. Yurieva1, W. Liao1, M. Poidinger1, F. Zolezzi1, G. Rancati2, N. Pavelka1
1Singapore Immunology Network (SIgN), Agency of Science, Technology and Research (A*STAR), 2Institute of Medical Biology, Agency of Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos #05, Singapore, Singapore

Aging/senescence

17.38     P124
Identifying the multidimensional controllers of aging
S. Maudsley1, J. van Gastel1, H. Leysen2, J. Hendrickx1
1Department of Biomedical Sciences, VIB - University of Antwerp, 2Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium

17.42     P125
mTOR regulates mRNA metabolism via mRNA binding proteins
S. Shetty, M.N. Hall
Biozentrum, University of Basel, Basel, Switzerland

17.46     P126
Sarcopenia chronicles: dynamics of gene expression during aging of rat skeletal muscles
A. Börsch1, J. Feige2, M. Rüegg1, M. Zavolan1
1Biozentrum, University of Basel, Basel, 2Nestlé Institute of Health Sciences, Lausanne, Switzerland

Model systems in disease

17.50     P127
Single cell RNA sequencing identifies novel cell types and distinct, transcriptional programs in the developing Drosophila ovary.
M. Slaidina, T. Banisch, R. Lehmann
Skirball Institute, New York University School of Medicine, New York, NY, United States

17.54     P128          
The role for coronin 1 in homeostatic CD4+ T cell expansion and survival in peripheral lymphoid organs
M. Mori, J. Ruer-Laventie, J. Pieters
Biozentrum, University of Basel, Basel, Switzerland

Microbial disease/pathogens

17.58     P129          
NCS1 regulates Ca2+-Dependent Focal Exocytosis of Golgi-derived Vesicles to Help Phagocytic uptake in Macrophages
N. Vashi1,2
1National Insstitute of Immunology, Delhi, 2International Centre for Genetic Engineering & Biotechnology, New Delhi, India

18.02     P130          
A strategic application of computational tools for the identification enoyl-acyl carrier protein reductase inhibitors
M.Y. Lone1,2, A. Manhas2, P.C. Jha3
1Department of Chemistry, Indian Institute of Technology Gandhinagar, 2School of Chemical Sciences, 3Centre for Applied Chemistry, Central University of Gujarat, Gandhinagar, India

18.06     P131          
Conformational Sampling of the Intrinsically Disordered C-Terminal Tail of DERA Is Important for Enzyme Catalysis
M. Schulte1,2, D. Petrovic2, P. Neudecker1,2, R. Hartmann2, J. Pietruszka3,4, S. Willbold5, D. Willbold1,2, V. Panwalkar1,2
1Institut für Physikalische Biologie, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, 2Institute of Complex Systems 6, Forschungszentrum Jülich, Jülich, 3Institute of Bioorganic Chemistry, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, 4Institute of Bio- and Geosciences 1: Biotechnology, 5Central Institute of Engineering, Electronics and Analytics, Forschungszentrum Jülich, Jülich, Germany

18.10     P132          
Uptake of pVEC Examined by Microfluidic Technology

M. Yuce1, K. Ulgen1, B. Sariyar Akbulut2, E. Ozkirimli Olmez1
1Chemical Engineering, Bogazici University, 2Bioengineering, Marmara University, Istanbul, Turkey

18.14     P133
A Microfluidic Device to Study Chemotaxis by High-Throughput Single-Cell Tracking
F. Wyss, M. Sangermani, U. Jenal
University of Basel / Biozentrum, Basel, Switzerland

Poster exhibition

17.30 – 18.30

EMBO Poster Session

EMBO Poster session 2

Poster exhibition

Friday 14 September 2018

09.00 – 10.15

EMBO Scientific Session

Plenary session 4: Neurodegenerative Disease

Chair:
John Hardy (University College London, United Kingdom)

09.00
Presenilin metastability in Alzheimer’s disease, implications for drug discovery

Lucía Chávez Gutiérrez (Catholic University Leuven, Leuven, Belgium)

09.25
Microglial dysfunction in neurodegenerative disorders

Christian Haass (Ludwig-Maximilians-University, Munich, Germany)

09.50
Gene silencing therapy for human neurodegenerative disease
Don W. Cleveland (Ludwig Institute for Cancer Research, La Jolla, United States)

Montreal

10.15 – 10.45

Coffee break at the exhibition

10.45 – 12.30

EMBO Scientific Session

Parallel session 5: Aging and senescence

Chair:
Judith Campisi (Buck Institute for Research on Aging, Novato, United States)

10.45
Cellular senescence, aging and longevity
Judith Campisi (Buck Institute for Research on Aging, Novato, United States)

11.10
Senescence in cancer therapy – not too bad, if not for good
Clemens A. Schmitt (Max Delbrück Center for Molecular Medicine, Berlin, Germany)  

11.35
An integrated view of cellular senescence and in vivo reprogramming

Manuel Serrano (Institute for Research in Biomedicine, Barcelona, Spain)

Abstract presentations

12.00
Longitudinal analysis of gene expression reveals widespread pleiotropic antagonism during aging of the short-lived fish Nothobranchius furzeri.
M. Mazzetto1,2, M. Baumgart2, M. Groth2, A. Martirosyan2, M. Ermolaeva2, M. Platzer2, A. Cellerino1,2
1Scuola Normale Superiore, Pisa, Italy, 2Fritz-Lipmann Institute, Jena, Germany

12.15
Identification and application of gene expression signatures of lifespan-extending interventions
A. Tyshkovskiy1,2, R.A. Miller3, V.N. Gladyshev1
1Division of Genetics, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, United States, 2Center for Data-Intensive Biomedicine and Biotechnology, Skolkovo Institute of Science and Technology, Moscow, Russian Federation, 3Department of Pathology and Geriatrics Center, University of Michigan, Ann Arbor, MI, United States

Montreal

10.45 – 12.30

EMBO Scientific Session

Parallel session 6: Model systems in disease

Chair:
Cayetano Gonzalez (Institute for Research in Biomedicine, Barcelona, Barcelona, Spain)

10.45
Using Drosophila tumours to understand malignant and normal growth during development
Cayetano Gonzalez (Institute for Research in Biomedicine, Barcelona, Barcelona, Spain)

11.10
Models and model systems: the nutritional geometry of health and ageing
Stephen Simpson (University of Sydney, Sydney, Australia)

11.35
When the young die old: the premature aging disease Progeria and Lamin A processing by ZMPSTE24
Susan Michaelis (Johns Hopkins University, Baltimore, United States)

Abstract presentations

12.00
Active chromatin markers H3K36me and MRG-1 drive heterochromatin spatial sequestration in differentiated cells in C. elegans
D.S. Cabianca1, C. Muñoz Jiménez2, V. Kalck1, D. Gaidatzis1, J. Padeken1, A. Seeber1, P. Askjaer2, S.M. Gasser1
1Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland, 2Andalusian Center for Developmental Biology, Sevilla, Spain

12.30
Human brain organoids with functional eyecups
J. Gopalakrishnan
University of Cologne, Cologne, Germany

Singapore

12.25 – 14.00

Lunch break

14.00 – 15.40

EMBO Scientific Session

Plenary session 5: Metabolic disorders – Diabetes and obesity

Chair:
Helena Edlund (University of Umeå, Sweden)

14.00
PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type2 diabetes patients
Helena Edlund (University of Umeå, Sweden)

14.25
Obesity and its metabolic consequences: lessons from human genetics
Stephen O'Rahilly (University of Cambridge, United Kingdom)

14.50
MicroRNAs and RNA-binding proteins as regulators of metabolism

Markus Stoffel (ETH, Zurich, Switzerland)

15.15
Adipose tissue expandability, lipotoxicity and the metabolic syndrome
Antonio Vidal-Puig (University of Cambridge, United Kingdom)

Montreal

15.40 – 15.55

EMBO Session

Closing address

Montreal

 

 

Subject to change.